Hypersensitivity and Infusion-Site Adverse Events with Intravenous Fosaprepitant after Anthracycline-Containing Chemotherapy: A Retrospective Study

Ralph V. Boccia, Thomas Ottoboni, Robert B. Geller et al.|Future Oncology|2018

Cited by 17